Article (Scientific journals)
A phase I trial of sunitinib, a tyrosine kinase inhibitor (TKI) combined with ionizing irradiation in rectal cancer
Coucke, Philippe
2009In Belgian Journal of Medical Oncology, 3 (3), p. 117
Peer Reviewed verified by ORBi
 

Files


Full Text
A phase I trial of sunitinib, a tyrosine kinase inhibitor (TKI) combined with ionizing irradiation in rectal cancer.pdf
Publisher postprint (264.92 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Oncology
Author, co-author :
Coucke, Philippe  ;  Université de Liège - ULiège > Radiothérapie
Language :
English
Title :
A phase I trial of sunitinib, a tyrosine kinase inhibitor (TKI) combined with ionizing irradiation in rectal cancer
Publication date :
2009
Journal title :
Belgian Journal of Medical Oncology
ISSN :
1784-7141
Publisher :
Ariez Medical Publishing, Amsterdam, Netherlands
Volume :
3
Issue :
3
Pages :
117
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 February 2010

Statistics


Number of views
29 (2 by ULiège)
Number of downloads
127 (2 by ULiège)

Bibliography


Similar publications



Contact ORBi